What is Voyager Therapeutics Inc?
, a biotechnology company, focuses on the human genetics for the cure of neurological diseases.
The story behind the price, the case for and against, and what could go wrong. Open a part to read it.
, a biotechnology company, focuses on the human genetics for the cure of neurological diseases. Its product pipeline includes VY1706, a tau silencing gene therapy and VY7523, an anti-tau antibody program for the treatment of alzheimer's disease. The company is listed on the NASDAQ in USA, operating in the Healthcare sector, with a market capitalisation of 107.66M.
A short list of Biotechnology names that are close enough in size to make side-by-side comparison useful.
| Shares sold | Shares bought | |
|---|---|---|
| 0-3months | 0 | 0 |
| 3-6months | 0 | 0 |
| 6-9months | 541,008 shares $156k | 0 |
| 9-12months | 320,286 shares $77k | 0 |